From Medical News Today
The results of a UK pilot study presented at a conference in the US this week have shown that a new test is able to distinguish samples of prostate cancer from samples of benign prostate disease and healthy prostate tissue 90 per cent of the time compared to the current PSA test only has a specificity of less than 50 per cent , considerably higher than current diagnostic tests.
With a 40% improvement in accuracy this new test appears to have fantastic potential.
It seems though that while the test may eventually replace the current PSA blood test the 'doctor digit test' will also still be utilised - bugger!
http://www.medicalnewstoday.com/articles/202934.php
The results of a UK pilot study presented at a conference in the US this week have shown that a new test is able to distinguish samples of prostate cancer from samples of benign prostate disease and healthy prostate tissue 90 per cent of the time compared to the current PSA test only has a specificity of less than 50 per cent , considerably higher than current diagnostic tests.
With a 40% improvement in accuracy this new test appears to have fantastic potential.
It seems though that while the test may eventually replace the current PSA blood test the 'doctor digit test' will also still be utilised - bugger!
http://www.medicalnewstoday.com/articles/202934.php






RSS Feed